In their study, Buendia et al. (2016) identified Nrf2 as a potential pivotal target in the antioxidant stress response associated with emerging neurodegenerative diseases, which is in accordance with the findings of the GAS study in treating neurological disorders. The gene discussed is NFE2L2; the disease is nervous system disorder.